Brief: Clovis Oncology Announces Preliminary Financial Results For Q4 And Full Year 2021
10/01/2022 13:03
Jan 10 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES PRELIMINARY FINANCIAL RESULTS
FOR THE
FOURTH QUARTER AND FULL YEAR 2021
* CLOVIS ONCOLOGY INC - ESTIMATED $35.5M - $36.1M IN RUBRACA
(RUCAPARIB) GLOBAL SALES FOR Q4 2021 AND $148.3M - $148.9M FOR
FY 2021
Source text for Eikon: ID:nBw4L2tzfa
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber